Hexagon Nutrition Limited (HEXAGON)
₹73.15 +1.09% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Hexagon Nutrition's revenue was ₹104 Cr (+43.2% year on year, -9.3% on the previous quarter), and net profit ₹8.1 Cr (+25.0% year on year); the operating margin was 11.3%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹104 | +43.2% | -9.3% |
| Operating profit | ₹11.7 | +16.8% | -22.1% |
| Net profit | ₹8.1 | +25.0% | -25.9% |
| EPS (₹) | 0.67 | +15.5% | -32.3% |
| Operating margin | 11.3% | — | — |
HEXAGON exchange data
NSE end-of-day data for
It closed at a price band (circuit) on 3 sessions in about the last 20.
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Hexagon Nutrition Limited has dispatched physical letters to shareholders whose email addresses are not registered, providing weblinks to access the Notice of its upcoming Extra-Ordinary General Meeting (EGM). The EGM is scheduled to be held on Wednesday, October 28, 2026, at 11:30 AM IST via Video Conference and Other Audio-Visual Means. The filing serves as a procedural compliance intimation under Regulation 30 of SEBI LODR Regulations without disclosing the specific resolutions to be voted on. In its recent quarterly performance for June 2026, the company reported revenue of Rs 104.31 crore and a net profit of Rs 8.07 crore.
- EGM scheduled for Wednesday, October 28, 2026, at 11:30 AM IST via VC/OAVM
- Letters dispatched to shareholders without registered email addresses with details to access notice via weblink
- Notice made available on company website under Regulation 46 disclosures as well as BSE and NSE
- Company reported June 2026 quarterly revenue of Rs 104.306 cr and net profit of Rs 8.073 cr
Hexagon Nutrition has issued a notice convening an Extraordinary General Meeting (EGM) on October 28, 2026, requisitioned by shareholders holding 45.81% equity. The meeting seeks shareholder approval to appoint 76-year-old Mr. Arun Purushottam Kelkar as Executive Director and Chairman for 5 years, along with annual remuneration of up to ₹1.82 crore. Additionally, approval is sought for annual remuneration of up to ₹2.42 crore for Managing Director Mr. Vikram Kelkar effective April 1, 2026. Remote e-voting is scheduled between October 25 and October 27, 2026.
- EGM requisitioned by members holding 56,296,871 shares (45.81% of paid-up equity capital)
- Proposed appointment of Mr. Arun Purushottam Kelkar (age 76) as Chairman & Executive Director for a 5-year tenure
- Proposed remuneration of up to ₹1,82,00,000 per annum for Mr. Arun Kelkar
- Proposed remuneration of up to ₹2,42,00,000 per annum for Managing Director Mr. Vikram Kelkar
- EGM date set for October 28, 2026, with cut-off date on October 21, 2026
Hexagon Nutrition's Board has taken note of requisition letters received on September 24, 2026, from promoter shareholders to convene an Extraordinary General Meeting (EGM). Shareholders holding 38.41% requested an EGM to appoint Mr. Arun Purushottam Kelkar as Executive Director and Chairman and approve his remuneration. Another requisition from shareholders holding 24.67% requested approval for remuneration payable to Managing Director Mr. Vikram Kelkar effective April 1, 2026. The board considered convening an EGM to seek shareholder approval for these matters.
- Requisition received from shareholders holding 38.41% equity to appoint Arun Purushottam Kelkar as Executive Director and Chairman
- Approval sought for remuneration of Managing Director Vikram Kelkar with effect from April 1, 2026, by 24.67% shareholding group
- Board considered proposal to convene an Extraordinary General Meeting (EGM) to seek shareholder approvals
- Trading window closed from October 1, 2026, until 48 hours after Q2 FY27 financial results declaration
Hexagon Nutrition Limited and Particles for Humanity have successfully completed the commercial-scale process validation of PFH-VAP. The product, a stable formulation of Vitamin A Palmitate intended for large-scale food fortification, is proposed to be marketed internationally under the brand name 'VIT A+'. While this validates the manufacturing feasibility at scale, financial details, expected revenue, and capex were not disclosed in the filing. In the recent quarter ending June 2026, Hexagon reported revenue of Rs 104.31 crore and net profit of Rs 8.07 crore.
- Completed commercial-scale process validation of PFH-VAP with partner Particles for Humanity on September 29, 2026
- Product is a stable formulation of Vitamin A Palmitate intended for large-scale food fortification
- Proposed to be marketed commercially under the brand name 'VIT A+' in international markets
- Hexagon reported Q1 Jun 2026 revenue of Rs 104.306 crore and net profit of Rs 8.073 crore
Hexagon Nutrition Limited announced that its Chairman & Executive Director, Arun Purushottam Kelkar, has completed his tenure and stepped down effective September 28, 2026, at the close of office hours. Kelkar has led the company since its incorporation. The company reported revenue of Rs 104.31 crore and net profit of Rs 8.07 crore in the June 2026 quarter. Investors should monitor subsequent filings regarding leadership succession and board reconstitution.
- Cessation of Arun Purushottam Kelkar as Chairman & Executive Director effective September 28, 2026
- Change occurred due to the completion of his scheduled term
- Company posted revenue of Rs 104.306 crore and net profit of Rs 8.073 crore in Q1 FY27 (Jun 2026)
Hexagon Nutrition Limited announced that its Chairman & Executive Director, Arun Purushottam Kelkar, has completed his tenure and stepped down effective September 28, 2026, at the close of office hours. Kelkar has led the company since its incorporation. The company reported revenue of Rs 104.31 crore and net profit of Rs 8.07 crore in the June 2026 quarter. Investors should monitor subsequent filings regarding leadership succession and board reconstitution.
- Cessation of Arun Purushottam Kelkar as Chairman & Executive Director effective September 28, 2026
- Change occurred due to the completion of his scheduled term
- Company posted revenue of Rs 104.306 crore and net profit of Rs 8.073 crore in Q1 FY27 (Jun 2026)
Hexagon Nutrition Limited reported an update regarding voting outcomes on certain shareholder resolutions, disclosing that Promoter shareholders had abstained from voting. The company is actively seeking an independent legal opinion to decide on the appropriate course of action under applicable law. Further details on the specific resolutions or financial implications were not disclosed in the filing. Investors should note this development follows the company's June 2026 quarterly net profit of Rs 8.073 cr on revenue of Rs 104.306 cr.
- Promoter shareholders abstained from voting on certain resolutions as of September 23, 2026
- Company is currently seeking an independent legal opinion to determine next steps
- Hexagon Nutrition reported June 2026 quarterly revenue of Rs 104.306 cr and net profit of Rs 8.073 cr
- Specific resolution details and voting percentage breakdowns were not disclosed
At Hexagon Nutrition's 33rd Annual General Meeting held on September 22, 2026, public shareholders pushed back on executive compensation and leadership continuity. Three special resolutions failed to pass: Resolution 7 (remuneration of Chairman Arun Kelkar), Resolution 8 (remuneration of MD Vikram Kelkar), and Resolution 11 (re-appointment of Arun Kelkar as Chairman & Executive Director), all receiving 60.86% votes against from voting members. However, routine items including adoption of FY26 financial statements, dividend declaration, and revision of Joint MD Dr. Nikhil Kelkar's remuneration were approved.
- Resolution 7 (remuneration of Chairman Arun Kelkar) rejected with 60.86% votes cast against (2,468,131 votes against vs 1,587,029 in favour)
- Resolution 8 (remuneration of MD Vikram Kelkar) rejected with 60.86% votes cast against (2,468,131 votes against vs 1,587,009 in favour)
- Resolution 11 (re-appointment of Arun Kelkar as Chairman & Executive Director) defeated with 60.86% votes against
- Resolution 9 (remuneration revision for Joint MD Dr. Nikhil Kelkar) passed with near-unanimous approval (4,054,824 votes in favour)
- Resolution 3 approving dividend declaration for FY 2025-26 passed with 100% of votes polled in favour
Hexagon Nutrition Limited disclosed under SEBI SAST Regulations that promoter and Managing Director Vikram Arun Kelkar purchased 10,000 equity shares via open market transactions on September 17, 2026. Following this minor acquisition, his personal shareholding marginally increased from 21.12% (2,59,61,344 shares) to 21.13% (2,59,71,344 shares). The total paid-up share capital remains unchanged at 12,29,18,109 shares. At current market prices of Rs 66.3, the acquired stake represents a nominal transaction value of roughly Rs 6.6 lakh.
- Promoter Vikram Arun Kelkar acquired 10,000 equity shares via the open market on September 17, 2026
- Acquisition represents 0.0081% of the company's total voting capital
- Total holding of the acquirer increased from 21.12% (2,59,61,344 shares) to 21.13% (2,59,71,344 shares)
- Total voting capital of Hexagon Nutrition stands at 12,29,18,109 equity shares
Hexagon Nutrition Limited disclosed that promoter and Managing Director Vikram Kelkar acquired 10,000 equity shares via open market transactions on September 17, 2026. This acquisition represents 0.0081% of the total share capital of the company. Following the transaction, his personal shareholding marginally increased from 21.12% (2,59,61,344 shares) to 21.13% (2,59,71,344 shares). Total equity share capital stands at 12,29,18,109 shares.
- 10,000 equity shares acquired by promoter Vikram Kelkar via open market
- Acquisition represents 0.0081% of total voting capital
- Holding increased from 21.12% (2,59,61,344 shares) to 21.13% (2,59,71,344 shares)
- Total diluted share capital remains unchanged at 12,29,18,109 shares
Hexagon Nutrition Limited disclosed an insider acquisition under SEBI SAST Regulations by Mr. Vikram Kelkar, Promoter and Managing Director. On September 17, 2026, he acquired 10,000 equity shares (0.0081% of voting capital) via open market transactions. Following this purchase, his personal shareholding marginally increased from 21.12% (2,59,61,344 shares) to 21.13% (2,59,71,344 shares). Total voting capital remains unchanged at 12,29,18,109 equity shares.
- Promoter & MD Vikram Kelkar acquired 10,000 equity shares via open market on September 17, 2026
- Acquisition represents 0.0081% of total equity/voting capital
- Pre-transaction holding was 2,59,61,344 shares (21.12%), increasing to 2,59,71,344 shares (21.13%)
- Total diluted equity voting capital stands at 12,29,18,109 shares
Hexagon Nutrition Limited disclosed an insider acquisition under SEBI SAST Regulation 29(2). Promoter and Managing Director Vikram Kelkar acquired 10,000 equity shares through open-market transactions on September 17, 2026. Following the purchase, his holding increased marginally from 21.12% (2,59,61,344 shares) to 21.13% (2,59,71,344 shares). The total voting share capital remains unchanged at 12,29,18,109 equity shares.
- Promoter & MD Vikram Kelkar acquired 10,000 equity shares via open market on September 17, 2026
- Acquisition represents 0.0081% of the total voting share capital
- Pre-transaction holding stood at 2,59,61,344 shares (21.12%)
- Post-transaction holding increased to 2,59,71,344 shares (21.13%)
- Total share capital of the company is 12,29,18,109 shares
Hexagon Nutrition Limited submitted a disclosure under Regulation 29(2) of SEBI SAST Regulations regarding an open market purchase by promoter and Managing Director Vikram Kelkar. On September 17, 2026, he acquired 10,000 equity shares, representing 0.0081% of the total voting capital. Following this acquisition, his holding increased marginally from 2,59,61,344 shares (21.12%) to 2,59,71,344 shares (21.13%). The total diluted share capital of the company stands at 12,29,18,109 equity shares.
- Promoter & MD Vikram Kelkar acquired 10,000 equity shares via open market on September 17, 2026
- Acquisition represents 0.0081% of the total share and voting capital
- Pre-acquisition stake stood at 2,59,61,344 shares (21.12%)
- Post-acquisition stake increased to 2,59,71,344 shares (21.13%)
- Total voting capital of the company is 12,29,18,109 shares
Hexagon Nutrition Limited has dispatched physical letters containing the web-link for its FY2025-26 Annual Report and AGM Notice to members whose email addresses are not registered. The company's 33rd Annual General Meeting is scheduled to be held on September 22, 2026, at 11:30 AM IST via Video Conference. This filing is a statutory compliance disclosure under Regulation 36(1)(b) of SEBI Listing Regulations.
- 33rd Annual General Meeting scheduled for September 22, 2026 at 11:30 AM IST via VC/OAVM
- Intimation pursuant to Regulation 36(1)(b) of SEBI LODR Regulations
- Web-link sent to shareholders without registered email addresses for accessing the FY2025-26 Annual Report
Hexagon Nutrition Limited received an Order-in-Original from the Commissioner of Customs, Chennai - III, raising a total demand and penalty of ₹1,04,71,989 plus applicable interest. The demand pertains to its amalgamated subsidiary, Hexagon Nutrition Exports Private Limited, regarding alleged misclassification of CTH codes for DTA unit sales. The total demand of ₹1.05 cr represents approximately 13% of the company's Jun 2026 quarterly net profit of ₹8.07 cr. Hexagon stated it strongly disagrees with the findings and is preparing to file an appeal before the appellate authority.
- Total customs demand, fine, and penalty amount to ₹1,04,71,989 plus applicable interest
- Breakdown includes ₹81,71,989 in Customs Duty, ₹15,00,000 in fine, and ₹8,00,000 in penalty
- Order received on 29 August 2026 alleging CTH code misclassification for sales to DTA units
- Pertains to erstwhile subsidiary Hexagon Nutrition Exports, amalgamated via NCLT order dated 14 January 2026
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
